Eagle Pharmaceuticals, Inc. (EGRX)
OTCMKTS · Delayed Price · Currency is USD
1.600
-1.400 (-46.67%)
Oct 9, 2025, 3:53 PM EDT
Eagle Pharmaceuticals Market Cap
Eagle Pharmaceuticals has a market cap or net worth of $39.07 million as of October 9, 2025. Its market cap has decreased by -50.44% in one year.
Market Cap
39.07M
Enterprise Value
n/a
Revenue
257.55M
Ranking
n/a
PE Ratio
3.29
Stock Price
$1.60
Market Cap Chart
Since February 12, 2014, Eagle Pharmaceuticals's market cap has decreased from 39.11M to 39.07M, a decrease of -0.10%. That is a compound annual growth rate of -0.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 39.07M | 500.00% |
| Dec 31, 2024 | 6.51M | -90.41% |
| Dec 29, 2023 | 67.92M | -82.15% |
| Dec 30, 2022 | 380.45M | -42.14% |
| Dec 31, 2021 | 657.57M | 8.37% |
| Dec 31, 2020 | 606.81M | -26.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 674.12M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 380.49M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 321.63M |
| American Oncology Network | 273.17M |
| Silence Therapeutics | 245.14M |